AbigailCaseMD

Journal Articles

• BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma  
  Weisberg, E., Chowdhury, B., Meng, C., Case, A.E., Ni, W., Garg, S., Sattler, M., Azab, A.K., Sun, J., Muz, B., Sanchez, D., Toure, A., Stone, R.M., Galinsky, I., Wine..., Blood Cancer Journal, 7/19/2022
• The combination of FLT3 and SYK kinase inhibitors is toxic to leukaemia cells with CBL mutations  
  Ellen Weisberg, Chengcheng Meng, Abigail E. Case, Hong L. Tiv, Prafulla C. Gokhale, Anthia A. Toure, Sara Buhrlage, Xiaoxi Liu, Jinhua Wang, Nathanael Gray, Richard St..., Journal of Cellular and Molecular Medicine
• Inhibitors of the Transcription Factor STAT3 Decrease Growth and Induce Immune Response Genes in Models of Malignant Pleural Mesothelioma (MPM)  
  Ladipot, M., Case, A.E., Larios, D. Gandler, H.I., Meng, C. Tošić, I., Weisberg, E. Poitras, M.J., Gokhale, P.C., Pawletz, C.P., Podar, K., Salgia, R., Saladi, S.V., G..., Cancers, 12/22/2020
• Effects of the multi-kinase inhibitor midostaurin in combination with chemotherapy in models of acute myeloid leukemia  
  Weisberg, E., Meng, C., Case, A.E., Tiv, H.L., Gokhale, P.C., Buhrlage, S., Yang, J., Liu, X., Wang, J., Gray, N., Adamia, S., Sattler, M., Stone, R., Griffin, J.D., J Cell Mol Med, 3/24/2020
• Inhibition of the deubiquitinase USP10 induces degradation of SYK  
  Yang, J., Meng, C., Weisberg, E., Case, A.E., Lamberto, I., Magin, R.S., Adamia, S., Wang, J., Gray, N., Liu, S., Stone, R., Sattler, M., Buhrlage, S., Griffin, J.D., British Journal of Cancer, 2/4/2020
• Expression of the eight GABAA receptor α subunits in the developing zebrafish central nervous system  
  Bryan Monesson-Olson, Jon J. McClain, Abigail E. Case, Hanna E. Dorman, Daniel R. Turkewitz, Aaron B. Steiner, Gerald B. Downes, PLOS ONE, 4/27/2018
• Join now to see all